← All trials
NCT03466528
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 16, 2016
- Primary completion
- Apr 30, 2018
- Completion date
- Jun 30, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of GlasgowLead sponsor
- University of GlasgowReponsible party - principal investigator
- University of GlasgowOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.